Similar to the investigation in malignant lymphoid cells [17], we observed that SRT2183 also halts the mitotic cycle and cellular demise in glioma cell lines accompanied by an increase of Bim and decrease of Bcl-2 and Bcl-xL. This evidence concerns the gene BCL2L1 and glioma.